Authors: Rosanna K. Martens, Chao Chen, David Ehmann, Mark Greve, Mark E. Seamone. Author Disclosure Block: R.K. Martens: None. C. Chen: None. D. Ehmann: None. M. Greve: None. M.E. Seamone: None.Purpose: To investigate the anatomic and visual outcomes of individuals undergoing pars plana vitrectomy (PPV) for uncomplicated, primary macula-off rhegmatogenous retinal detachment (RRD) with and without macular internal limiting...

At the end of this session participants will be able to:Demonstrate increased knowledge in the diagnosis and management of several infectious uveitis pathologies  Describe various retinal imaging findings in uveitis Describe various retinal imaging findings in uveitisCanMEDS Roles:Medical Expert, Scholar 

At the end of this session participants will be able to:• Demonstrate increased knowledge on the use of biosimilar agents and fluid analysis in the diagnosis and management of uveitis. • Integrate pearls on the management of ocular hypertension, postoperative inflammation in uveitis. CanMEDS Roles: Medical Expert, Scholar 

Learning ObjectivesAt the end of this session, participants will be able to:Assess and manage vitreoretinal lymphomaDescribe the choroidal changes in the treatment of diabetic retinopathyIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar 

Authors: Samir Touma, Andrei-Alexandru Szigiato, Fares Antaki, Simon Javidi, Renaud Duval, Ghassan Cordahi, Sebastien Olivier, Flavio Rezende. Author Disclosure Block: S. Touma: All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity; Name of for-profit or not-for-profit organization(s); Bayer Inc.. All other investments or...

Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar

Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar

Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...

Learning ObjectivesAt the end of this session, participants will be able to:To understand the incredible advancements that continue to be made in the management of age related macular degeneration.Appreciate how to select the best therapeutic option to minimize vision loss in macular degeneratio...

Author’s Name(s): Wai-Ching Lam, Timothy Lai, Xiaodong Sun, Shih-Jen Chen, Xin Zhang, Andrea Schulze, Tobias Machewitz, Min Zhao, Sergio LealAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Apellis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Novartis, Membership on an advisory panel, standing committee or board of directors, Amgen, Membership on an advi...

Author’s Name(s): Rajinder Nirwan, Robert L. Avery, Sara J. Haug, David Tabano, Gloria Chi, Manuel Amador, Aachal Kotecha, Philippe Margaron, Ming Yang Author’s Disclosure Block: Rajinder Nirwan: Roche, Employment/honoraria/consulting fees; Robert L. Avery: Consultant: Adverum, Alcon, Alimera, Allergan, Amgen, Apellis, AsclepiX, Bausch + Lomb, Cardinal, Clearside Biomedical, Coherus, EyePoint, Genentech, Inc., Helio Vision, InFocus Capital Partner...

Author’s Name(s): Mélanie Hébert, Valérie Gagné, Jean-Philippe Rozon, Serge Bourgault, Mathieu Caissie, Laurence Letartre, Éric Tourville, Ali DiraniAuthor’s Disclosure Block: Mélanie Hébert: Bayer, Grant/research support, Vision Health Research Network, Grant/research support, Fighting Blindness Canada, Grant/research support; Valérie Gagné: none; Jean-Philippe Rozon: none; Serge Bourgault: none; Mathieu Caissie: none; Laurence Letartre: none; Éric To...

Author’s Name(s): Reut Shor, Andrew Mihalache, Atefeh Noori, Renana Shor, Radha Kohly, Marko Popovic, Rajeev MuniAuthor’s Disclosure Block: Reut Shor, none; Andrew Mihalache, none; Atefeh Noori, none; Renana Shor, none; Radha Kohly, none; Marko Popovic, none; Rajeev Muni, noneAbstract BodyPurpose: To determine whether glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated with increased risk of developing neova...

Author’s Name(s): Andrew Mihalache, Ryan Huang, Marko Popovic, Sue Demian, Rajeev MuniAuthor’s Disclosure Block: Andrew Mihalache: none; Ryan Huang: none; Marko Popovic: Financial support (to institution) – PSI Foundation, Fighting Blindness Canada.; Sue Demian: none; Rajeev Muni: Consultant – Alcon, Apellis, AbbVie, Bayer, Bausch Health, Roche; Financial Support (to institution) – Alcon, AbbVie, Bayer, Novartis, Roche.Abstract Body

Author’s Name(s): Andrei-Alexandru Szigiato, Christiana Dinah, Francis Abreu, Pablo Arrisi, Aachal Kotecha, Ying Liu, Liliana Paris, Anne-Cecile Retiere, Jeffrey WillisAuthor’s Disclosure Block: Andrei-Alexandru Szigiato: Apellis, Employment/honoraria/consulting fees, Roche, Employment/honoraria/consulting fees; Christiana Dinah: Consultancy: AbbVie, Apellis, Boehringer Ingelheim, Janssen, Ora Clinical, Roche; Lecture fees: Apellis, Roche, Topcon; Inst...

Author’s Name(s): Bernard Hurley, Srinivas Sadda, Jennifer Lim, Yiyi Wang, Derrek Hibar, Andreas Maunz, Huanxiang Lu, Thomas Albrecht, Kara Gibson, Jeffrey Willis, Dolly ChangAuthor’s Disclosure Block: Bernard Hurley: Allergan, Employment/honoraria/consulting fees, Novartis, Employment/honoraria/consulting fees, Alcon Canada, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Roche, Employment/honoraria/consulting fees, ...

Author’s Name(s): Nirojini Sivachandran, Stela Vujosevic, Christiana Dinah, Roger Goldberg, Michael Ip, Ehsan Rahimy, Manuel Amador, Kara Gibson, Carl Glittenberg, Andreas MaunzAuthor’s Disclosure Block: Nirojini Sivachandran: Roche, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Apellis, Employment/honoraria/consulting fees; Stela Vujosevic: Consultant: AbbVie/Allergan, Apellis, Bayer, Boehringer Ingelheim, Novartis...

Author’s Name(s): Marko Popovic, Ryan Huang, Sumana Naidu, Andrew Mihalache, Peter Kertes, David Sarraf, SriniVas Sadda, Rajeev Muni, Radha KohlyAuthor’s Disclosure Block: Marko Popovic, none; Ryan Huang, none; Sumana Naidu, none; Andrew Mihalache, none; Peter Kertes, none; David Sarraf, none; SriniVas Sadda, none; Rajeev Muni, none; Radha Kohly, noneAbstract BodyPurpose: To investigate the sociodemographic and clinical fact...

Author’s Name(s): Parnian Arjmand, Ramin Khoramnia, Paolo Lanzetta, Anat Loewenstein, Michael Stewart, Richard Gale, Marion Munk, Ursula Schmidt-Ott, April McCullough, Claudia Tueckmantel, Alyson BerlinerAuthor’s Disclosure Block: Parnian Arjmand: Hoffman La Roche, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Apobiologix, Employment/honoraria/consulting fees, Young MDConnect, Employment/honoraria/consulting fees; R...

Author’s Name(s): Wai-Ching Lam, Shih-Jen Chen, Gemmy Cheung, Tomohiro Iida, Adrian Koh, Won Ki Lee, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Timothy LaiAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Novartis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Amgen, Membership on an advisory panel, standing committee or board of directors, Apellis, ...

Author’s Name(s): Yosra Er-reguyeg, El Yazid Rhalem, Eunice Linh You, Anas Abu-Dieh, Mélanie Hébert, Huixin Zhang, Serge Bourgault, Mathieu Caissie, Éric Tourville, Ali DiraniAuthor’s Disclosure Block: Yosra Er-reguyeg: none; El Yazid Rhalem: none; Eunice Linh You: none; Anas Abu-Dieh: none; Mélanie Hébert: none; Huixin Zhang: none; Serge Bourgault: none; Mathieu Caissie: none; Éric Tourville: Department of Ophthalmology, Hospital Saint-Sacrement, Lava...

Author’s Name(s): Aurora Pecaku, Isabela Matins Melo, Rajeev MuniAuthor’s Disclosure Block: Aurora Pecaku, none; Isabela Matins Melo, none; Rajeev Muni, Silber Target FundAbstract BodyPurpose: To report the primary anatomic reattachment rate with pars plana vitrectomy-suprachoroidal viscopexy (VIT–SCVEXY) for rhegmatogenous retinal detachment (RRD) repair. Secondary outcomes included Snellen's visual acuity (VA) at postopera...

Author’s Name(s): Kirk Stephenson, Deepika Parameswarappa, Mark Seamone, Flavio Rizende, Cynthia Qian, Rajeev Muni, Peter Kertes, Ian MacDonald, Ajoy Vincent, Elise HeonAuthor’s Disclosure Block: Kirk Stephenson: Foundation Fighting Blindness Career Development / Clinical Research Fellowship Award, Grant/research support; Deepika Parameswarappa: none; Mark Seamone: none; Flavio Rizende: none; Cynthia Qian: none; Rajeev Muni: none; Peter Kertes: none; I...

Author’s Name(s): Lia Huo, Daniela Isaacs-Bernal, Ellie Monroe, Carter Teal, Thierry Léveillard, Shira Albeck, Tamar Unger, Valerie Wallace, Robert Fluhr, Anubhav Garg, Molly ShoichetAuthor’s Disclosure Block: Lia Huo, none; Daniela Isaacs-Bernal, none; Ellie Monroe, none; Carter Teal, none; Thierry Léveillard, none; Shira Albeck, none; Tamar Unger, none; Valerie Wallace, none; Robert Fluhr, none; Anubhav Garg, none; Molly Shoichet, none...

Author’s Name(s): Jennifer Ling, Kirk Stephenson, Olubayo Kolawole, Lica Chui, Cheryl Gregory-Evans, Kevin Gregory-Evans, Maryam Soleimani, Patrick MaAuthor’s Disclosure Block: Jennifer Ling, none; Kirk Stephenson, none; Olubayo Kolawole, none; Lica Chui, none; Cheryl Gregory-Evans, none; Kevin Gregory-Evans, none; Maryam Soleimani, none; Patrick Ma, noneAbstract BodyPurpose: To assess the effect of belzutifan, a first-in-cl...

Learning ObjectivesAt the end of this session, participants will be able to:Understand how the home OCT works and its practical application in the management of retinal diseases.

Learning ObjectivesAt the end of this session, participants will be able to:Apply ROP screening guidelines specific to CanadaDescribe pathophysiology of ROP and future potential screening tools

Learning ObjectivesAt the end of this session, participants will be able to:Assess uveitis guidelines to determine when referral to a uveitis specialist or rheumatologist for immunomodulatory treatment is necessary to prevent complications.Describe a new cl...